Kontribusi Kepatuhan Konsumsi Obat Antihipertensi dan Terkendalinya Tekanan Darah Pasien Hipertensi di Puskesmas Cisauk, Kabupaten Tangerang, Banten
DOI:
https://doi.org/10.28932/jmh.v5i1.6097Keywords:
tekanan darah tinggi, tensi, kepatuhan minum obat, puskesmas Cisauk Tangerang, MMAS-8Abstract
Hipertensi merupakan masalah kesehatan dengan tingkat prevalensi tertinggi di dunia. WHO mencatat bahwa terdapat 1 dalam 5 orang dengan hipertensi yang terkontrol disebabkan kepatuhan penderita hipertensi dalam mengonsumsi obat yang masih kurang. Walaupun beberapa penelitian melaporkan mengenai pengaruh kepatuhan mengonsumsi obat antihipertensi dengan terkendalinya tekanan darah tinggi, namun masih terdapat perbedaan pada kebermaknaan pada hasil penelitiannya. Tujuan penelitian ini adalah untuk membuktikan kontribusi kepatuhan konsumsi obat antihipertensi dengan terkendalinya tekanan darah pada penderita hipertensi. Penelitian ini menggunakan metode studi potong lintang terhadap 78 penderita tekanan darah tinggi di Puskesmas Cisauk yang memenuhi kriteria penelitian. Data kepatuhan meminum obat antihipertensi diamati dengan kuesioner Morrisky Medication Adherence Scale 8 (MMAS-8). Hasil penelitian menunjukkan 47 (60,3%) subyek hipertensi tidak patuh terhadap pengobatan hipertensi, sedangkan 56 (71,8%) subyek memiliki tekanan darah yang tidak terkendali yaitu >140/90. Hubungan antara kedua variabel pada penderita hipertensi di Puskesmas Cisauk yang dianalisa dengan metode chi-square menunjukkan kebermaknaan dengan p<0,0001 dan OR=5,35. Penelitian ini menyimpulkan apabila pasien tidak patuh minum obat antihipertensi maka kemungkinan akan mengalami hipertensi 5,35 kali lebih besar.Downloads
References
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.
Badan Penelitian dan Pengembangan Kesehatan. Hasil Utama Riskesdas 2018. Kementerian Kesehatan RI; 2018.
Kurnianto A, Sunjaya DK, Rinawan FR, Hilmanto D. Prevalence of Hypertension and Its Associated Factors among Indonesian Adolescents. Int J Hypertens. 2020;2020:1–7.
Tabrizi JS, Sadeghi-Bazargani H, Farahbakhsh M, Nikniaz L, Nikniaz Z. Prevalence and Associated Factors of Prehypertension and Hypertension in Iranian Population: The Lifestyle Promotion Project (LPP). PLOS ONE. 2016;11(10):e0165264.
Singh S, Shankar R, Singh GP. Prevalence and Associated Risk Factors of Hypertension: A Cross-Sectional Study in Urban Varanasi. Int J Hypertens. 2017;2017:1–10.
Sorato MM, Davari M, Kebriaeezadeh A, Sarrafzadegan N, Shibru T. Societal economic burden of hypertension at selected hospitals in southern Ethiopia: a patient-level analysis. BMJ Open. 2022;12(4):e056627.
Arredondo A, Aviles R. Hypertension and Its Effects on the Economy of the Health System for Patients and Society: Suggestions for Developing Countries. Am J Hypertens. 2014;27(4):635–6.
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334–57.
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults. JAMA. 2014;311(5):507.
Turana Y, Tengkawan J, Soenarta AA. Asian management of hypertension: Current status, home blood pressure, and specific concerns in Indonesia. JCH. 2020;22(3):483–5.
Petrie JR, Guzik TJ, Touyz RM. Diabetes, Hypertension, and cardiovascular disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol. 2018;34(5):575–84.
Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cífková R, Dominiczak AF, et al. Hypertension. Nature Reviews Disease Primers. 2018;4(1):18014.
World Health Organization. Hypertension [Internet]. Who.int. World Health Organization: WHO; 2021.
Gupta P, Patel P, Štrauch B, Lai FY, Akbarov A, Marešová V, et al. Risk factors for nonadherence to antihypertensive treatment. Hypertension. 2017;69(6):1113–20.
Morrison A, Stauffer ME, Kaufman AS. Defining medication adherence in individual patients. Patient Prefer Adherence. 2015;9:893–7.
Okello S, Nasasira B, Muiru ANW, Muyingo A. Validity and Reliability of a Self-Reported Measure of Antihypertensive Medication Adherence in Uganda. PLOS ONE. 2016 Jul 1;11(7):e0158499.
Butler MJ, Tanner RM, Muntner P, Shimbo D, Bress AP, Shallcross AJ, et al. Adherence to antihypertensive medications and associations with blood pressure among African Americans with hypertension in the Jackson Heart Study. J Am Soc Hypertens. 2017;11(9):581-588.e5.
Khayyat SM, Khayyat SMS, Hyat Alhazmi RS, Mohamed MMA, Abdul Hadi M. Predictors of Medication Adherence and Blood Pressure Control among Saudi Hypertensive Patients Attending Primary Care Clinics: A Cross-Sectional Study. PLOS ONE. 2017;12(1):e0171255.
Glasser SP, Vitolins M, Rocco M v, Still CH, Cofield SS, Haley WE, et al. Is Medication Adherence Predictive of Cardiovascular Outcomes and Blood Pressure Control? The Systolic Blood Pressure Intervention Trial (SPRINT). Am J Hypertens. 2022;35(2):182–91.
Liberty IA, Pariyana P, Roflin E, Waris L. Determinan Kepatuhan Berobat Pasien Hipertensi Pada Fasilitas Kesehatan Tingkat I. Jurnal Penelitian dan Pengembangan Pelayanan Kesehatan. 2018; 12:58–65.
Matsumura K, Arima H, Tominaga M, Ohtsubo T, Sasaguri T, Fujii K, et al. Impact of antihypertensive medication adherence on blood pressure control in hypertension: the COMFORT study. QJM. 2013;106(10):909–14.
Choudhry NK, Kronish IM, Vongpatanasin W, Ferdinand KC, Pavlik VN, Egan BM, et al. Medication Adherence and Blood Pressure Control: A Scientific Statement from the American Heart Association. Hypertension. 2022;79(1):e1-e14.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Shirley I Moningkey, Iegreat Aprilyanri, I Gusti AN Hirania, Lidia Arita, Wahyuni L Atmodjo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain the copyright and grant the journal right of first publication with the work
simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. - Authors are able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
